Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
Jazz Pharmaceuticals
Jazz Pharmaceuticals
Activities:
Pharmaceutical
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Graphs and graph data science in drug discovery
Life sciences data expert Dr Alexander Jarasch discusses what work being done at the Institut de Recherches Servier can teach us about using modern data technologies for early...
Why smaller CDMOs should enhance their operational efficiency now: a CPHI expert guide
CPHI experts advise smaller CDMO's to invest in supply chain resilience, friend shoring and AI to keep up with the predicted uptick in funding for 2025
CPI collaborates with industry leaders to expedite drug manufacturing via digitisation
Digitising manufacturing technologies could allow enhanced ability to scale production, reduce costs and expedite the process
Janssen to adopt Johnson & Johnson brand as the company celebrates 100 years of UK operation
The company's pharmaceutical and medical technology segments will combine under the Johnson & Johnson brand name in the UK
Upcoming event
ASGCT Annual Meeting 2024
7-11 May, 2024 | Meeting | Portland, OR
See all
Related Content
Manufacturing
Jazz Pharmaceuticals announces UK manufacturing investment
Due to open in 2024, the facility is designed to support the company’s two cannabis-based medicines and support future capacity for medicines under development
Regulatory
Hikma enters settlement agreement with Jazz for sodium oxybate
Jazz will grant Hikma and West-Ward the right to sell an authorised generic of Xyrem in the US
Design & Build
Jazz Pharmaceuticals among ISPE FOYA winners
Ardmac supplied and installed the cleanroom in the biopharmaceutical company's winning facility in Ireland
Finance
Jazz Pharmaceuticals buys Alize Pharma II for €18m
Alize Pharma II is developing treatments for acute lymphoblastic leukaemia
Pharmaceutical
Jazz Pharmaceuticals names Russell Cox as Chief Operating Officer
Cox was formerly EVP and Chief Commercial Officer at the biopharmaceuticals company
Manufacturing
Jazz Pharmaceuticals to build new manufacturing and development facility in Ireland
It is expected to open in 2016 and create up to 50 new jobs when fully operational
Ingredients
Jazz Pharmaceuticals moves to buy EUSA Pharma
Terms include $650 million in cash plus a potential $50 m milestone payment
Subscribe now